跳至主要内容
临床试验/NL-OMON20627
NL-OMON20627暂停不适用

Randomized controlled multicenter phase III trial comparing cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer (SOCceR study).

Radboud University Nijmegen Medical Centre0 个研究点目标入组 230 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
230

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age ≥ 18 years;
  • 2. First recurrence of histologically or cytologically proven epithelial ovarian cancer, primaryperitoneal cancer or fallopian tube cancer of FIGO stage Ic-IV (FIGO system 1988);

排除标准

  • 1. Participation in interfering trial;
  • 2. Non-epithelial or borderline ovarian tumours;

研究者

发起方
Radboud University Nijmegen Medical Centre

相似试验

Surgery in recurrent ovarian cancer: The SOCceR... | 临床试验